Wednesday, October 20, 2021
Home News Moderna Says It Will Build a Vaccine Factory in Africa

Moderna Says It Will Build a Vaccine Factory in Africa


JOHANNESBURG — Moderna said on Thursday that it planned to build a vaccine manufacturing facility in Africa, news that was welcomed for the long-term but that does not address the continent’s immediate need for Covid-19 vaccines.

The company said that a new “state of the art” facility would eventually produce up to 500 million doses a year of Moderna’s mRNA vaccine, which has shown an efficacy rate of more than 90 percent in preventing Covid-19. The plant will, in time, also produce other Moderna vaccines, the company said.

Building vaccine manufacturing sites in Africa will increase the continent’s future access to the drugs. But it does not answer calls from African leaders and activists to waive patent laws that would give more drugmakers access to details on how coronavirus vaccines are produced. It also does not address the continent’s immediate Covid-19 vaccine shortages.

“It doesn’t necessarily solve our problems today,” Dr. John Nkengasong, the director of the Africa Centers for Disease Control and Prevention, said in a regular news briefing on Thursday. “The problems we have are quick access to vaccines, redistribution of vaccines, making sure that certain licenses are provided so that manufacturing can start regionally.”

Moderna’s announcement comes amid mounting pressure on biotech firms to share their expertise with manufacturers in countries that desperately need more coronavirus vaccine doses.

The drug makers Pfizer and BioNTech said in July that they had partnered with Biovac, a public-private partnership pharmaceutical company in Cape Town. In Gqeberha, the South African coastal city formerly known as Port Elizabeth, Johnson & Johnson has partnered with Aspen, a local manufacturer, in a fill-and-finish manufacturing process.

Moderna said that it expected to invest up to $500 million in its future site, and that its facility would manufacture the doses with fill-and-finish capacity, in addition to packaging facilities. It said it would now begin the process of identifying which country would host the plant.

“While we are still working to increase capacity in our current network to deliver vaccines for the ongoing pandemic in 2022, we believe it is important to invest in the future,” said Stephane Bancel, Moderna’s chief executive.

African leaders had already established the Partnerships for African Vaccine Manufacturing, which works within an existing “ecosystem” of Africa’s vaccine needs. Launched in April, it has political backing from the continent’s leaders, including Presidents Cyril Ramaphosa of South Africa and Paul Kagame of Rwanda.

Moderna, an American drug company, developed its coronavirus vaccine with billions of dollars in taxpayer money and received initial research and development funding from Covax, the vaccine sharing facility supported by the global vaccine alliance Gavi and the World Health Organization.



Source link

RELATED ARTICLES

The Olympic Torch Arrives in Beijing Under Cloud of Protests, Covid

The Olympic torch arrived in Beijing on Wednesday, beginning a countdown to a Winter Games being held under the shadow of the coronavirus...

Syria: Deadly blast on military bus in Damascus

At least 13 people are reported to have died in the bloodiest attack in the Syrian capital in years. Source link

Uttarakhand: At least 46 killed in floods in Himalayan state

Unusually heavy rainfall has triggered flash floods in India's northern state of Uttarakhand. Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisment -

Most Popular

The Olympic Torch Arrives in Beijing Under Cloud of Protests, Covid

The Olympic torch arrived in Beijing on Wednesday, beginning a countdown to a Winter Games being held under the shadow of the coronavirus...

Recent Comments